BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1205392 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(Cl)cc2)C2CCN(C)CC2)cc1 InChI=1S/C24H31ClN2O3/c1-18(2)30-23-10-6-20(7-11-23)17-29-24(28)27(22-12-14-26(3)15-13-22)16-19-4-8-21(25)9-5-19/h4-11,18,22H,12-17H2,1-3H3 HLNJMBAQALLQNH-UHFFFAOYSA-N 570515 US11440884, Example 1 5-hydroxytryptamine receptor 2A Human 0.200 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570515&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520965 473131749 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205393 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1 InChI=1S/C25H33FN2O3/c1-19(2)17-30-24-10-6-21(7-11-24)18-31-25(29)28(23-12-14-27(3)15-13-23)16-20-4-8-22(26)9-5-20/h4-11,19,23H,12-18H2,1-3H3 YIIZZYCHWJDNIR-UHFFFAOYSA-N 570516 US11440884, Example 2 5-hydroxytryptamine receptor 2A Human 0.126 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570516&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520745 473131750 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205394 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@H]2CCNC[C@H]2F)cc1 InChI=1S/C23H28F2N2O3/c1-16(2)30-20-9-5-18(6-10-20)15-29-23(28)27(22-11-12-26-13-21(22)25)14-17-3-7-19(24)8-4-17/h3-10,16,21-22,26H,11-15H2,1-2H3/t21-,22+/m1/s1 KAVJAYJEJLOWME-YADHBBJMSA-N 570517 US11440884, Example 3a::[4-(propan-2-yloxy)phenyl]methyl N-[(4-fluorophenyl)methyl]-N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate (3a) 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570517&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520514 473131751 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205395 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCNC[C@@H]2F)cc1 InChI=1S/C23H28F2N2O3/c1-16(2)30-20-9-5-18(6-10-20)15-29-23(28)27(22-11-12-26-13-21(22)25)14-17-3-7-19(24)8-4-17/h3-10,16,21-22,26H,11-15H2,1-2H3/t21-,22+/m0/s1 KAVJAYJEJLOWME-FCHUYYIVSA-N 570524 US11440884, Example 3b::[4-(propan-2-yloxy)phenyl]methyl N-[(4-fluorophenyl)methyl]-N-[(3S,4R)-3-fluoropiperidin-4-yl]carbamate (3b) 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570524&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520751 473131758 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205396 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@H]2CCN(C)C[C@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)31-21-10-6-19(7-11-21)16-30-24(29)28(14-18-4-8-20(25)9-5-18)23-12-13-27(3)15-22(23)26/h4-11,17,22-23H,12-16H2,1-3H3/t22-,23+/m1/s1 QMPLMLQOCFBDRN-PKTZIBPZSA-N 570525 [4-(propan-2-yloxy)phenyl]methyl N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (4a)::US11440884, Example 4a 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570525&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520477 473131759 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205397 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCN(C)C[C@@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)31-21-10-6-19(7-11-21)16-30-24(29)28(14-18-4-8-20(25)9-5-18)23-12-13-27(3)15-22(23)26/h4-11,17,22-23H,12-16H2,1-3H3/t22-,23+/m0/s1 QMPLMLQOCFBDRN-XZOQPEGZSA-N 570526 US11440884, Example 4b::[4-(propan-2-yloxy)phenyl]methyl N-[(3S,4R)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (4b) 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570526&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 151611561 473131760 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205398 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@H]2CCNC[C@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)15-30-21-9-5-19(6-10-21)16-31-24(29)28(23-11-12-27-13-22(23)26)14-18-3-7-20(25)8-4-18/h3-10,17,22-23,27H,11-16H2,1-2H3/t22-,23+/m1/s1 CVXGZCFGUCZPDD-PKTZIBPZSA-N 570527 US11440884, Example 5a::[4-(2-methylpropoxy)phenyl]methyl N-[(4-fluorophenyl)methyl]-N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate (5a) 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570527&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 156326388 473131761 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205399 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCNC[C@@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)15-30-21-9-5-19(6-10-21)16-31-24(29)28(23-11-12-27-13-22(23)26)14-18-3-7-20(25)8-4-18/h3-10,17,22-23,27H,11-16H2,1-2H3/t22-,23+/m0/s1 CVXGZCFGUCZPDD-XZOQPEGZSA-N 570528 US11440884, Example 5b::[4-(2-methylpropoxy)phenyl]methyl N-[(4-fluorophenyl)methyl]-N-[(3S,4R)-3-fluoropiperidin-4-yl]carbamate (5b) 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570528&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521161 473131762 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205400 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@H]2CCN(C)C[C@H]2F)cc1 InChI=1S/C25H32F2N2O3/c1-18(2)16-31-22-10-6-20(7-11-22)17-32-25(30)29(14-19-4-8-21(26)9-5-19)24-12-13-28(3)15-23(24)27/h4-11,18,23-24H,12-17H2,1-3H3/t23-,24+/m1/s1 DIFBDFWIYRWTRY-RPWUZVMVSA-N 570529 US11440884, Example 6a::[4-(2-methylpropoxy)phenyl]methyl N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (6a) 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570529&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535166 473131763 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205401 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCN(C)C[C@@H]2F)cc1 InChI=1S/C25H32F2N2O3/c1-18(2)16-31-22-10-6-20(7-11-22)17-32-25(30)29(14-19-4-8-21(26)9-5-19)24-12-13-28(3)15-23(24)27/h4-11,18,23-24H,12-17H2,1-3H3/t23-,24+/m0/s1 DIFBDFWIYRWTRY-BJKOFHAPSA-N 570530 US11440884, Example 6b::[4-(2-methylpropoxy)phenyl]methyl N-[(3S,4R)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (6b) 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570530&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 150035700 473131764 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205402 CC(C)COc1ccc(OC(=O)N(Cc2ccc(F)cc2)[C@H]2CCNC[C@H]2F)cc1 InChI=1S/C23H28F2N2O3/c1-16(2)15-29-19-7-9-20(10-8-19)30-23(28)27(22-11-12-26-13-21(22)25)14-17-3-5-18(24)6-4-17/h3-10,16,21-22,26H,11-15H2,1-2H3/t21-,22+/m1/s1 XLWHXYIBDSIBJP-YADHBBJMSA-N 570532 4-(2-methylpropoxy)phenyl N-[(4-fluorophenyl)methyl]-N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate (7a)::US11440884, Example 7a 5-hydroxytryptamine receptor 2A Human 39.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570532&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520439 473131766 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205403 CC(C)COc1ccc(OC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCNC[C@@H]2F)cc1 InChI=1S/C23H28F2N2O3/c1-16(2)15-29-19-7-9-20(10-8-19)30-23(28)27(22-11-12-26-13-21(22)25)14-17-3-5-18(24)6-4-17/h3-10,16,21-22,26H,11-15H2,1-2H3/t21-,22+/m0/s1 XLWHXYIBDSIBJP-FCHUYYIVSA-N 570533 4-(2-methylpropoxy)phenyl N-[(4-fluorophenyl)-methyl]-N-[(3S,4R)-3-fluoropiperidin-4-yl]carbamate (7b)::US11440884, Example 7b 5-hydroxytryptamine receptor 2A Human 39.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570533&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520756 473131767 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205404 CC(C)COc1ccc(OC(=O)N(Cc2ccc(F)cc2)[C@H]2CCN(C)C[C@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)16-30-20-8-10-21(11-9-20)31-24(29)28(14-18-4-6-19(25)7-5-18)23-12-13-27(3)15-22(23)26/h4-11,17,22-23H,12-16H2,1-3H3/t22-,23+/m1/s1 VVKFSUWYKRMLQB-PKTZIBPZSA-N 570534 4-(2-methylpropoxy)phenyl N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (8a)::US11440884, Example 8a 5-hydroxytryptamine receptor 2A Human 100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570534&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520979 473131768 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205405 CC(C)COc1ccc(OC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCN(C)C[C@@H]2F)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)16-30-20-8-10-21(11-9-20)31-24(29)28(14-18-4-6-19(25)7-5-18)23-12-13-27(3)15-22(23)26/h4-11,17,22-23H,12-16H2,1-3H3/t22-,23+/m0/s1 VVKFSUWYKRMLQB-XZOQPEGZSA-N 570538 4-(2-methylpropoxy)phenyl N-[(3S,4R)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (8b)::US11440884, Example 8b 5-hydroxytryptamine receptor 2A Human 100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570538&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520503 473131772 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205406 CC(C)COc1ccc(CCOC(=O)N(Cc2ccc(F)cc2)[C@H]2CCNC[C@H]2F)cc1 InChI=1S/C25H32F2N2O3/c1-18(2)17-32-22-9-5-19(6-10-22)12-14-31-25(30)29(24-11-13-28-15-23(24)27)16-20-3-7-21(26)8-4-20/h3-10,18,23-24,28H,11-17H2,1-2H3/t23-,24+/m1/s1 VAWYQKOSISWXHX-RPWUZVMVSA-N 570539 2-[4-(2-methylpropoxy)phenyl]ethyl N-[(4-fluorophenyl)methyl]-N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate; trifluoroacetic acid (9a)::US11440884, Example 9a 5-hydroxytryptamine receptor 2A Human 63.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570539&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520973 473131773 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205407 CC(C)COc1ccc(CCOC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCNC[C@@H]2F)cc1 InChI=1S/C25H32F2N2O3/c1-18(2)17-32-22-9-5-19(6-10-22)12-14-31-25(30)29(24-11-13-28-15-23(24)27)16-20-3-7-21(26)8-4-20/h3-10,18,23-24,28H,11-17H2,1-2H3/t23-,24+/m0/s1 VAWYQKOSISWXHX-BJKOFHAPSA-N 570540 2-[4-(2-methylpropoxy)phenyl]ethyl N-[(4-fluorophenyl)methyl]-N-[(3S,4R)-3-fluoropiperidin-4-yl]carbamate; trifluoroacetic acid (9b)::US11440884, Example 9b 5-hydroxytryptamine receptor 2A Human 63.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570540&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520992 473131774 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205408 CC(C)COc1ccc(CCOC(=O)N(Cc2ccc(F)cc2)[C@H]2CCN(C)C[C@H]2F)cc1 InChI=1S/C26H34F2N2O3/c1-19(2)18-33-23-10-6-20(7-11-23)13-15-32-26(31)30(16-21-4-8-22(27)9-5-21)25-12-14-29(3)17-24(25)28/h4-11,19,24-25H,12-18H2,1-3H3/t24-,25+/m1/s1 JEZFZYPMSITVPJ-RPBOFIJWSA-N 570541 2-[4-(2-methylpropoxy)phenyl]ethyl N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)methyl]carbamate (10a)::US11440884, Example 10a 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570541&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520510 473131775 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205409 CC(C)COc1ccc(CCOC(=O)N(Cc2ccc(F)cc2)[C@@H]2CCN(C)C[C@@H]2F)cc1 InChI=1S/C26H34F2N2O3/c1-19(2)18-33-23-10-6-20(7-11-23)13-15-32-26(31)30(16-21-4-8-22(27)9-5-21)25-12-14-29(3)17-24(25)28/h4-11,19,24-25H,12-18H2,1-3H3/t24-,25+/m0/s1 JEZFZYPMSITVPJ-LOSJGSFVSA-N 570542 2-[4-(2-methyl-propoxy)phenyl]ethyl N-[(3S,4R)-3-fluoro-1-methylpiperidin-4-yl]-N-[(4-fluorophenyl)-methyl]carbamate (10b)::US11440884, Example 10b 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570542&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535242 473131776 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205410 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCNCC2)cc1 InChI=1S/C23H28F2N2O3/c1-16(2)30-21-7-3-17(4-8-21)15-29-23(28)27(20-9-11-26-12-10-20)14-18-5-6-19(24)13-22(18)25/h3-8,13,16,20,26H,9-12,14-15H2,1-2H3 XMVDFZZSLNKDQN-UHFFFAOYSA-N 570543 US11440884, Example 11 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570543&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521220 473131777 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205411 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1 InChI=1S/C24H31FN2O3/c1-18(2)30-23-10-6-20(7-11-23)17-29-24(28)27(22-12-14-26(3)15-13-22)16-19-4-8-21(25)9-5-19/h4-11,18,22H,12-17H2,1-3H3 AKCIEGOUVHGKOX-UHFFFAOYSA-N 570544 US11440884, Example 12 5-hydroxytryptamine receptor 2A Human 0.251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570544&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520500 473131778 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205412 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C24H30F2N2O3/c1-17(2)31-22-8-4-18(5-9-22)16-30-24(29)28(21-10-12-27(3)13-11-21)15-19-6-7-20(25)14-23(19)26/h4-9,14,17,21H,10-13,15-16H2,1-3H3 VZUBAKOHHHWMMN-UHFFFAOYSA-N 570545 US11440884, Example 13 5-hydroxytryptamine receptor 2A Human 0.126 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570545&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520468 473131779 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205413 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O3/c1-18(2)16-31-23-8-4-19(5-9-23)17-32-25(30)29(22-10-12-28(3)13-11-22)15-20-6-7-21(26)14-24(20)27/h4-9,14,18,22H,10-13,15-17H2,1-3H3 CJNZPYWVCWOHFM-UHFFFAOYSA-N 570546 US11440884, Example 14 5-hydroxytryptamine receptor 2A Human 25.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570546&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520958 473131780 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205414 COc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C22H26F2N2O3/c1-25-11-9-19(10-12-25)26(14-17-5-6-18(23)13-21(17)24)22(27)29-15-16-3-7-20(28-2)8-4-16/h3-8,13,19H,9-12,14-15H2,1-2H3 IPSZIEFQSAHHOO-UHFFFAOYSA-N 570549 US11440884, Example 15 5-hydroxytryptamine receptor 2A Human 0.501 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570549&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520540 473131783 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205415 COc1ccc(CSC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C22H26F2N2O2S/c1-25-11-9-19(10-12-25)26(14-17-5-6-18(23)13-21(17)24)22(27)29-15-16-3-7-20(28-2)8-4-16/h3-8,13,19H,9-12,14-15H2,1-2H3 JRGXVXPKCDEBEN-UHFFFAOYSA-N 570550 US11440884, Example 16 5-hydroxytryptamine receptor 2A Human 25.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570550&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520508 473131784 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205416 CC(C)Oc1ccc(cc1)C(OC(=O)N(Cc1ccc(F)cc1)C1CCN(C)CC1)C(F)(F)F InChI=1S/C25H30F4N2O3/c1-17(2)33-22-10-6-19(7-11-22)23(25(27,28)29)34-24(32)31(21-12-14-30(3)15-13-21)16-18-4-8-20(26)9-5-18/h4-11,17,21,23H,12-16H2,1-3H3 HVCKPENRUUCWPI-UHFFFAOYSA-N 570553 US11440884, Example 17 5-hydroxytryptamine receptor 2A Human 31.6 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570553&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521299 473131787 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205417 CC(C)Oc1ccc(COC(=O)Oc2ccc(cc2)[N+]([O-])=O)cc1 InChI=1S/C17H17NO6/c1-12(2)23-15-7-3-13(4-8-15)11-22-17(19)24-16-9-5-14(6-10-16)18(20)21/h3-10,12H,11H2,1-2H3 KPVJARDWSWGQCE-UHFFFAOYSA-N 570555 US11440884, Example 18::[4-(propan-2-yloxy)phenyl]methyl N-[(7S,8aS)-octahydroindolizin-7-yl]-N-[(4-fluorophenyl)methyl]carbamate (18) 5-hydroxytryptamine receptor 2A Human 0.016 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570555&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535038 473131789 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205418 CC(C)Oc1ccc(CC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C24H30F2N2O2/c1-17(2)30-22-8-4-18(5-9-22)14-24(29)28(21-10-12-27(3)13-11-21)16-19-6-7-20(25)15-23(19)26/h4-9,15,17,21H,10-14,16H2,1-3H3 OUPXACJGGGNLPH-UHFFFAOYSA-N 570558 US11440884, Example 19 5-hydroxytryptamine receptor 2A Human 5.01 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570558&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520975 473131792 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205419 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)c(F)c1 InChI=1S/C25H32F2N2O2/c1-18(2)17-31-23-9-6-20(24(27)15-23)14-25(30)29(22-10-12-28(3)13-11-22)16-19-4-7-21(26)8-5-19/h4-9,15,18,22H,10-14,16-17H2,1-3H3 XJIAEZGSHRTKJD-UHFFFAOYSA-N 570559 US11440884, Example 20 5-hydroxytryptamine receptor 2A Human 6.31 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570559&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520674 473131793 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205420 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1F InChI=1S/C25H32F2N2O2/c1-18(2)17-31-24-9-6-20(14-23(24)27)15-25(30)29(22-10-12-28(3)13-11-22)16-19-4-7-21(26)8-5-19/h4-9,14,18,22H,10-13,15-17H2,1-3H3 XHVWPINRESYOLN-UHFFFAOYSA-N 570560 US11440884, Example 21 5-hydroxytryptamine receptor 2A Human 2.51 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570560&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520761 473131794 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205421 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O2/c1-18(2)17-31-23-8-4-19(5-9-23)14-25(30)29(22-10-12-28(3)13-11-22)16-20-6-7-21(26)15-24(20)27/h4-9,15,18,22H,10-14,16-17H2,1-3H3 HOLJHOBKXRAOTP-UHFFFAOYSA-N 570561 US11440884, Example 22 5-hydroxytryptamine receptor 2A Human 6.31 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570561&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520964 473131795 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205422 CCOc1ccc(CC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C23H28F2N2O2/c1-3-29-21-8-4-17(5-9-21)14-23(28)27(20-10-12-26(2)13-11-20)16-18-6-7-19(24)15-22(18)25/h4-9,15,20H,3,10-14,16H2,1-2H3 IWXVOLBCUPYNSA-UHFFFAOYSA-N 570562 US11440884, Example 23 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570562&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520766 473131796 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205423 CCCCOc1ccc(CC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O2/c1-3-4-15-31-23-9-5-19(6-10-23)16-25(30)29(22-11-13-28(2)14-12-22)18-20-7-8-21(26)17-24(20)27/h5-10,17,22H,3-4,11-16,18H2,1-2H3 WTLMYJPQHGRIAR-UHFFFAOYSA-N 570563 US11440884, Example 24 5-hydroxytryptamine receptor 2A Human 63.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570563&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520509 473131797 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205424 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OCC=C)cc1 InChI=1S/C24H28F2N2O3/c1-3-14-30-22-8-4-18(5-9-22)17-31-24(29)28(21-10-12-27(2)13-11-21)16-19-6-7-20(25)15-23(19)26/h3-9,15,21H,1,10-14,16-17H2,2H3 LBPCZOAGJVSUHL-UHFFFAOYSA-N 570564 US11440884, Example 26 5-hydroxytryptamine receptor 2A Human 0.501 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570564&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 156326372 473131798 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205425 CCOc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C23H28F2N2O3/c1-3-29-21-8-4-17(5-9-21)16-30-23(28)27(20-10-12-26(2)13-11-20)15-18-6-7-19(24)14-22(18)25/h4-9,14,20H,3,10-13,15-16H2,1-2H3 IFYJKZSGSDJWTI-UHFFFAOYSA-N 570565 US11440884, Example 25 5-hydroxytryptamine receptor 2A Human 0.200 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570565&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535042 473131799 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205426 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OCCCF)cc1 InChI=1S/C24H29F3N2O3/c1-28-12-9-21(10-13-28)29(16-19-5-6-20(26)15-23(19)27)24(30)32-17-18-3-7-22(8-4-18)31-14-2-11-25/h3-8,15,21H,2,9-14,16-17H2,1H3 GZVWGOBAWMFLKG-UHFFFAOYSA-N 570566 US11440884, Example 27 5-hydroxytryptamine receptor 2A Human 0.158 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570566&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520735 473131800 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205427 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OC(CF)CF)cc1 InChI=1S/C24H28F4N2O3/c1-29-10-8-20(9-11-29)30(15-18-4-5-19(27)12-23(18)28)24(31)32-16-17-2-6-21(7-3-17)33-22(13-25)14-26/h2-7,12,20,22H,8-11,13-16H2,1H3 YQSXZGVURBXISD-UHFFFAOYSA-N 570567 US11440884, Example 28 5-hydroxytryptamine receptor 2A Human 0.079 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570567&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521199 473131801 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205428 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OCC(C)(C)O)cc1 InChI=1S/C25H32F2N2O4/c1-25(2,31)17-33-22-8-4-18(5-9-22)16-32-24(30)29(21-10-12-28(3)13-11-21)15-19-6-7-20(26)14-23(19)27/h4-9,14,21,31H,10-13,15-17H2,1-3H3 QYIFMZRJWFNPDP-UHFFFAOYSA-N 570568 US11440884, Example 29 5-hydroxytryptamine receptor 2A Human 0.063 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570568&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535243 473131802 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205429 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OC2CC2)cc1 InChI=1S/C24H28F2N2O3/c1-27-12-10-20(11-13-27)28(15-18-4-5-19(25)14-23(18)26)24(29)30-16-17-2-6-21(7-3-17)31-22-8-9-22/h2-7,14,20,22H,8-13,15-16H2,1H3 LEUFGZLVCJIGEE-UHFFFAOYSA-N 570569 US11440884, Example 30 5-hydroxytryptamine receptor 2A Human 0.032 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570569&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 150924766 473131803 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205430 CC(C)COc1ccc(CC(=O)N(Cc2ccc(Cl)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32ClFN2O2/c1-18(2)17-31-23-8-4-19(5-9-23)14-25(30)29(22-10-12-28(3)13-11-22)16-20-6-7-21(26)15-24(20)27/h4-9,15,18,22H,10-14,16-17H2,1-3H3 UZDRGCZLDFKILC-UHFFFAOYSA-N 570570 US11440884, Example 31 5-hydroxytryptamine receptor 2A Human 50.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570570&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520959 473131804 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205431 COc1cc(F)c(F)cc1CN(C1CCN(C)CC1)C(=O)Cc1ccc(OC(C)C)cc1 InChI=1S/C25H32F2N2O3/c1-17(2)32-21-7-5-18(6-8-21)13-25(30)29(20-9-11-28(3)12-10-20)16-19-14-22(26)23(27)15-24(19)31-4/h5-8,14-15,17,20H,9-13,16H2,1-4H3 LUNQGTNMJLTSQC-UHFFFAOYSA-N 570571 US11440884, Example 32 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570571&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520903 473131805 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205432 COc1cc(F)c(CN(C2CCN(C)CC2)C(=O)Cc2ccc(OCC(C)C)cc2)c(F)c1 InChI=1S/C26H34F2N2O3/c1-18(2)17-33-21-7-5-19(6-8-21)13-26(31)30(20-9-11-29(3)12-10-20)16-23-24(27)14-22(32-4)15-25(23)28/h5-8,14-15,18,20H,9-13,16-17H2,1-4H3 JIEGRYCRDTXMQD-UHFFFAOYSA-N 570572 US11440884, Example 33 5-hydroxytryptamine receptor 2A Human 31.6 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570572&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520466 473131806 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205433 CC(C)Oc1ccc(CC(=O)N(Cc2ccc(F)c(F)c2F)C2CCN(C)CC2)cc1 InChI=1S/C24H29F3N2O2/c1-16(2)31-20-7-4-17(5-8-20)14-22(30)29(19-10-12-28(3)13-11-19)15-18-6-9-21(25)24(27)23(18)26/h4-9,16,19H,10-15H2,1-3H3 GGGWVNCPTBLGBW-UHFFFAOYSA-N 570573 US11440884, Example 34 5-hydroxytryptamine receptor 2A Human 39.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570573&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520981 473131807 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205434 COc1cc(F)c(F)cc1CN(C1CCN(C)CC1)C(=O)OCc1ccc(OCC(C)C)cc1 InChI=1S/C26H34F2N2O4/c1-18(2)16-33-22-7-5-19(6-8-22)17-34-26(31)30(21-9-11-29(3)12-10-21)15-20-13-23(27)24(28)14-25(20)32-4/h5-8,13-14,18,21H,9-12,15-17H2,1-4H3 LQWYYOIKZUJASE-UHFFFAOYSA-N 570574 US11440884, Example 35 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570574&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520970 473131808 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205435 COc1cc(F)c(CN(C2CCN(C)CC2)C(=O)OCc2ccc(OCC(C)C)cc2)c(F)c1 InChI=1S/C26H34F2N2O4/c1-18(2)16-33-21-7-5-19(6-8-21)17-34-26(31)30(20-9-11-29(3)12-10-20)15-23-24(27)13-22(32-4)14-25(23)28/h5-8,13-14,18,20H,9-12,15-17H2,1-4H3 DAHDPGAJWBRKTP-UHFFFAOYSA-N 570575 US11440884, Example 36 5-hydroxytryptamine receptor 2A Human 1.000 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570575&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520988 473131809 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205436 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)c(F)c2F)C2CCN(C)CC2)cc1 InChI=1S/C25H31F3N2O3/c1-17(2)15-32-21-7-4-18(5-8-21)16-33-25(31)30(20-10-12-29(3)13-11-20)14-19-6-9-22(26)24(28)23(19)27/h4-9,17,20H,10-16H2,1-3H3 ZVYNRVSTUGABIE-UHFFFAOYSA-N 570576 US11440884, Example 37 5-hydroxytryptamine receptor 2A Human 1.26 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570576&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520969 473131810 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205437 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(Cl)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C24H30ClFN2O3/c1-17(2)31-22-8-4-18(5-9-22)16-30-24(29)28(21-10-12-27(3)13-11-21)15-19-6-7-20(25)14-23(19)26/h4-9,14,17,21H,10-13,15-16H2,1-3H3 KQARTGBZEPANAH-UHFFFAOYSA-N 570586 US11440884, Example 38 5-hydroxytryptamine receptor 2A Human 0.501 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570586&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520803 473131820 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205438 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OCCF)cc1 InChI=1S/C23H27F3N2O3/c1-27-11-8-20(9-12-27)28(15-18-4-5-19(25)14-22(18)26)23(29)31-16-17-2-6-21(7-3-17)30-13-10-24/h2-7,14,20H,8-13,15-16H2,1H3 HVFILSVIFFTTIH-UHFFFAOYSA-N 570587 US11440884, Example 39 5-hydroxytryptamine receptor 2A Human 0.158 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570587&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520465 473131821 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205439 CCCCOc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O3/c1-3-4-15-31-23-9-5-19(6-10-23)18-32-25(30)29(22-11-13-28(2)14-12-22)17-20-7-8-21(26)16-24(20)27/h5-10,16,22H,3-4,11-15,17-18H2,1-2H3 UFXYIZKAVNFQFG-UHFFFAOYSA-N 570588 US11440884, Example 40 5-hydroxytryptamine receptor 2A Human 1.26 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570588&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520513 473131822 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205440 CCc1ccc(CN(C2CCN(C)CC2)C(=O)OCc2ccc(OC(C)C)cc2)c(F)c1 InChI=1S/C26H35FN2O3/c1-5-20-6-9-22(25(27)16-20)17-29(23-12-14-28(4)15-13-23)26(30)31-18-21-7-10-24(11-8-21)32-19(2)3/h6-11,16,19,23H,5,12-15,17-18H2,1-4H3 ZKIYYCDCHZJIRM-UHFFFAOYSA-N 570589 US11440884, Example 41 5-hydroxytryptamine receptor 2A Human 2.51 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570589&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 156326387 473131823 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205441 COC(=O)C(C)(C)CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OC(C)C)cc1 InChI=1S/C29H38F2N2O5/c1-20(2)38-25-10-6-21(7-11-25)18-37-28(35)33(17-22-8-9-23(30)16-26(22)31)24-12-14-32(15-13-24)19-29(3,4)27(34)36-5/h6-11,16,20,24H,12-15,17-19H2,1-5H3 NRJZALQQPQQSNH-UHFFFAOYSA-N 570590 US11440884, Example 42 5-hydroxytryptamine receptor 2A Human 10.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570590&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520727 473131824 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205442 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(CC(C)(C)C(O)=O)CC2)cc1 InChI=1S/C28H36F2N2O5/c1-19(2)37-24-9-5-20(6-10-24)17-36-27(35)32(16-21-7-8-22(29)15-25(21)30)23-11-13-31(14-12-23)18-28(3,4)26(33)34/h5-10,15,19,23H,11-14,16-18H2,1-4H3,(H,33,34) PEXUHNVYWCKIJK-UHFFFAOYSA-N 570591 US11440884, Example 43 5-hydroxytryptamine receptor 2A Human 3.16 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570591&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520773 473131825 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205443 CCN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OC(C)C)cc1 InChI=1S/C25H32F2N2O3/c1-4-28-13-11-22(12-14-28)29(16-20-7-8-21(26)15-24(20)27)25(30)31-17-19-5-9-23(10-6-19)32-18(2)3/h5-10,15,18,22H,4,11-14,16-17H2,1-3H3 BMNPRZBEHBNXPP-UHFFFAOYSA-N 570592 US11440884, Example 44 5-hydroxytryptamine receptor 2A Human 0.398 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570592&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520755 473131826 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205444 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(CC2)C2CC2)cc1 InChI=1S/C26H32F2N2O3/c1-18(2)33-24-9-3-19(4-10-24)17-32-26(31)30(16-20-5-6-21(27)15-25(20)28)23-11-13-29(14-12-23)22-7-8-22/h3-6,9-10,15,18,22-23H,7-8,11-14,16-17H2,1-2H3 FQXCBNSBQSDTTH-UHFFFAOYSA-N 570593 US11440884, Example 45 5-hydroxytryptamine receptor 2A Human 2.51 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570593&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520491 473131827 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205445 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2F)C2CCN(CC2)C2COC2)cc1 InChI=1S/C26H32F2N2O4/c1-18(2)34-24-7-3-19(4-8-24)15-33-26(31)30(14-20-5-6-21(27)13-25(20)28)22-9-11-29(12-10-22)23-16-32-17-23/h3-8,13,18,22-23H,9-12,14-17H2,1-2H3 LSRHVJHATLOSPY-UHFFFAOYSA-N 570594 US11440884, Example 46 5-hydroxytryptamine receptor 2A Human 25.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570594&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520442 473131828 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205446 COc1ccc(CN(C2CCN(C)CC2)C(=O)Cc2ccc(OCC(C)C)cc2)c(F)c1 InChI=1S/C26H35FN2O3/c1-19(2)18-32-23-8-5-20(6-9-23)15-26(30)29(22-11-13-28(3)14-12-22)17-21-7-10-24(31-4)16-25(21)27/h5-10,16,19,22H,11-15,17-18H2,1-4H3 DQDISRHLYXVHKC-UHFFFAOYSA-N 570595 US11440884, Example 47 5-hydroxytryptamine receptor 2A Human 7.94 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570595&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520523 473131829 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205447 CC(C)Oc1ccc(\C=C\C(=O)N(Cc2ccc(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H30F2N2O2/c1-18(2)31-23-9-4-19(5-10-23)6-11-25(30)29(22-12-14-28(3)15-13-22)17-20-7-8-21(26)16-24(20)27/h4-11,16,18,22H,12-15,17H2,1-3H3/b11-6+ BMSYKKZAGXGSMR-IZZDOVSWSA-N 570596 US11440884, Example 48 5-hydroxytryptamine receptor 2A Human 39.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570596&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520678 473131830 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205448 CC(C)Oc1ccc(CC(=O)N(Cc2ccc(F)cc2F)[C@@H]2CCN(C)C[C@@H]2F)cc1 InChI=1S/C24H29F3N2O2/c1-16(2)31-20-8-4-17(5-9-20)12-24(30)29(23-10-11-28(3)15-22(23)27)14-18-6-7-19(25)13-21(18)26/h4-9,13,16,22-23H,10-12,14-15H2,1-3H3/t22-,23+/m0/s1 ODXDDPXTDOQWBK-XZOQPEGZSA-N 570597 US11440884, Example 49 5-hydroxytryptamine receptor 2A Human 10.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570597&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137535044 473131831 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205449 CC(C)COc1ccc(CC(=O)N(Cc2ccc(Cl)cc2C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C26H32ClF3N2O2/c1-18(2)17-34-23-8-4-19(5-9-23)14-25(33)32(22-10-12-31(3)13-11-22)16-20-6-7-21(27)15-24(20)26(28,29)30/h4-9,15,18,22H,10-14,16-17H2,1-3H3 LGSYVPCEXLZQHF-UHFFFAOYSA-N 570598 US11440884, Example 50 5-hydroxytryptamine receptor 2A Human 20.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570598&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520963 473131832 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205450 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2OC(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C26H32F4N2O3/c1-18(2)17-34-23-8-4-19(5-9-23)14-25(33)32(22-10-12-31(3)13-11-22)16-20-6-7-21(27)15-24(20)35-26(28,29)30/h4-9,15,18,22H,10-14,16-17H2,1-3H3 ARHKFQBJTSNXTF-UHFFFAOYSA-N 570599 US11440884, Example 51 5-hydroxytryptamine receptor 2A Human 200 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570599&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520746 473131833 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205451 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2C)C2CCN(C)CC2)cc1 InChI=1S/C26H35FN2O2/c1-19(2)18-31-25-9-5-21(6-10-25)16-26(30)29(24-11-13-28(4)14-12-24)17-22-7-8-23(27)15-20(22)3/h5-10,15,19,24H,11-14,16-18H2,1-4H3 RGHHGXVRMMYLRV-UHFFFAOYSA-N 570600 US11440884, Example 52 5-hydroxytryptamine receptor 2A Human 200 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570600&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520511 473131834 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205452 COc1ccc(CN(C2CCN(C)CC2)C(=O)Cc2ccc(OCC(C)C)cc2)c(Cl)c1 InChI=1S/C26H35ClN2O3/c1-19(2)18-32-23-8-5-20(6-9-23)15-26(30)29(22-11-13-28(3)14-12-22)17-21-7-10-24(31-4)16-25(21)27/h5-10,16,19,22H,11-15,17-18H2,1-4H3 ILGGIZOXKJADKI-UHFFFAOYSA-N 570601 US11440884, Example 53 5-hydroxytryptamine receptor 2A Human 126 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570601&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520968 473131835 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205453 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(Cl)cc2C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C25H30ClF3N2O3/c1-17(2)34-22-8-4-18(5-9-22)16-33-24(32)31(21-10-12-30(3)13-11-21)15-19-6-7-20(26)14-23(19)25(27,28)29/h4-9,14,17,21H,10-13,15-16H2,1-3H3 LRVPDTWETNYZQI-UHFFFAOYSA-N 570602 US11440884, Example 54 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570602&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520492 473131836 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205454 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2OC(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C25H30F4N2O4/c1-17(2)34-22-8-4-18(5-9-22)16-33-24(32)31(21-10-12-30(3)13-11-21)15-19-6-7-20(26)14-23(19)35-25(27,28)29/h4-9,14,17,21H,10-13,15-16H2,1-3H3 RWWWHSYTMSLVGF-UHFFFAOYSA-N 570603 US11440884, Example 55 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570603&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520728 473131837 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205455 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2C)C2CCN(C)CC2)cc1 InChI=1S/C25H33FN2O3/c1-18(2)31-24-9-5-20(6-10-24)17-30-25(29)28(23-11-13-27(4)14-12-23)16-21-7-8-22(26)15-19(21)3/h5-10,15,18,23H,11-14,16-17H2,1-4H3 WYTHWVFUWGLLHI-UHFFFAOYSA-N 570604 US11440884, Example 56 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570604&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521014 473131838 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205456 COc1ccc(CN(C2CCN(C)CC2)C(=O)OCc2ccc(OC(C)C)cc2)c(Cl)c1 InChI=1S/C25H33ClN2O4/c1-18(2)32-22-8-5-19(6-9-22)17-31-25(29)28(21-11-13-27(3)14-12-21)16-20-7-10-23(30-4)15-24(20)26/h5-10,15,18,21H,11-14,16-17H2,1-4H3 MEDGMGZBKGDUNY-UHFFFAOYSA-N 570605 US11440884, Example 57 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570605&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520753 473131839 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205457 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C25H32ClFN2O3/c1-18(2)16-31-23-8-4-19(5-9-23)17-32-25(30)29(22-10-12-28(3)13-11-22)15-20-6-7-21(27)14-24(20)26/h4-9,14,18,22H,10-13,15-17H2,1-3H3 KZBZCAATISNNQB-UHFFFAOYSA-N 570606 US11440884, Example 58 5-hydroxytryptamine receptor 2A Human 7.94 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570606&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520764 473131840 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205458 CC(C)COc1ccc(CC(=O)N(Cc2ccc(Cl)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C25H32Cl2N2O2/c1-18(2)17-31-23-8-4-19(5-9-23)14-25(30)29(22-10-12-28(3)13-11-22)16-20-6-7-21(26)15-24(20)27/h4-9,15,18,22H,10-14,16-17H2,1-3H3 GHYAGKHSEXNMTH-UHFFFAOYSA-N 570608 US11440884, Example 59 5-hydroxytryptamine receptor 2A Human 251 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570608&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520754 473131842 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205459 CC(C)Oc1ccc(CC(=O)N(Cc2ccc(Cl)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C24H30Cl2N2O2/c1-17(2)30-22-8-4-18(5-9-22)14-24(29)28(21-10-12-27(3)13-11-21)16-19-6-7-20(25)15-23(19)26/h4-9,15,17,21H,10-14,16H2,1-3H3 IXFRWSQJBCYDBY-UHFFFAOYSA-N 570609 US11440884, Example 60 5-hydroxytryptamine receptor 2A Human 316 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570609&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520499 473131843 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205460 CC(C)COc1ccc(CC(=O)N(Cc2ccc(F)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C25H32ClFN2O2/c1-18(2)17-31-23-8-4-19(5-9-23)14-25(30)29(22-10-12-28(3)13-11-22)16-20-6-7-21(27)15-24(20)26/h4-9,15,18,22H,10-14,16-17H2,1-3H3 VZLSSERMJCLXMQ-UHFFFAOYSA-N 570610 US11440884, Example 61 5-hydroxytryptamine receptor 2A Human 200 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570610&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520946 473131844 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205461 CC(C)Oc1ccc(CC(=O)N(Cc2ccc(F)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C24H30ClFN2O2/c1-17(2)30-22-8-4-18(5-9-22)14-24(29)28(21-10-12-27(3)13-11-21)16-19-6-7-20(26)15-23(19)25/h4-9,15,17,21H,10-14,16H2,1-3H3 XWCKYAKOPRFJBG-UHFFFAOYSA-N 570611 US11440884, Example 62 5-hydroxytryptamine receptor 2A Human 316 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570611&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520506 473131845 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205462 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C24H30ClFN2O3/c1-17(2)31-22-8-4-18(5-9-22)16-30-24(29)28(21-10-12-27(3)13-11-21)15-19-6-7-20(26)14-23(19)25/h4-9,14,17,21H,10-13,15-16H2,1-3H3 AXFITELJDVIDSZ-UHFFFAOYSA-N 570612 US11440884, Example 63 5-hydroxytryptamine receptor 2A Human 3.98 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570612&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520635 473131846 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205463 CC(C)COc1ccc(COC(=O)N(Cc2ccc(Cl)cc2Cl)C2CCN(C)CC2)cc1 InChI=1S/C25H32Cl2N2O3/c1-18(2)16-31-23-8-4-19(5-9-23)17-32-25(30)29(22-10-12-28(3)13-11-22)15-20-6-7-21(26)14-24(20)27/h4-9,14,18,22H,10-13,15-17H2,1-3H3 XVGCDDFGLPOUJJ-UHFFFAOYSA-N 570613 US11440884, Example 64 5-hydroxytryptamine receptor 2A Human 10.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570613&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520985 473131847 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205464 CC(C)Oc1ccc(COC(=O)N(Cc2c(F)ccc(C)c2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O3/c1-17(2)32-21-8-6-19(7-9-21)16-31-25(30)29(20-11-13-28(4)14-12-20)15-22-23(26)10-5-18(3)24(22)27/h5-10,17,20H,11-16H2,1-4H3 NUJCWMLWFOMVTC-UHFFFAOYSA-N 570614 US11440884, Example 65 5-hydroxytryptamine receptor 2A Human 20.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570614&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520469 473131848 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205465 CC(C)Oc1ccc(COC(=O)N(Cc2c(F)ccc(F)c2F)C2CCN(C)CC2)cc1 InChI=1S/C24H29F3N2O3/c1-16(2)32-19-6-4-17(5-7-19)15-31-24(30)29(18-10-12-28(3)13-11-18)14-20-21(25)8-9-22(26)23(20)27/h4-9,16,18H,10-15H2,1-3H3 YHOYKOZXTPJAMK-UHFFFAOYSA-N 570615 US11440884, Example 66 5-hydroxytryptamine receptor 2A Human 3.98 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570615&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520487 473131849 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205466 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)c(C)c2F)C2CCN(C)CC2)cc1 InChI=1S/C25H32F2N2O3/c1-17(2)32-22-8-5-19(6-9-22)16-31-25(30)29(21-11-13-28(4)14-12-21)15-20-7-10-23(26)18(3)24(20)27/h5-10,17,21H,11-16H2,1-4H3 NCQVGECINMLZTF-UHFFFAOYSA-N 570616 US11440884, Example 67 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570616&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137521011 473131850 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205467 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(C)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C25H33FN2O3/c1-18(2)31-23-9-6-20(7-10-23)17-30-25(29)28(22-11-13-27(4)14-12-22)16-21-8-5-19(3)15-24(21)26/h5-10,15,18,22H,11-14,16-17H2,1-4H3 PNVAJFCYIQYKGG-UHFFFAOYSA-N 570617 US11440884, Example 68 5-hydroxytryptamine receptor 2A Human 50.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570617&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520515 473131851 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205468 CC(C)COc1ccc(CC(=O)N(Cc2ccc(cc2F)C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C26H32F4N2O2/c1-18(2)17-34-23-8-4-19(5-9-23)14-25(33)32(22-10-12-31(3)13-11-22)16-20-6-7-21(15-24(20)27)26(28,29)30/h4-9,15,18,22H,10-14,16-17H2,1-3H3 QQTQBUBAEXYENX-UHFFFAOYSA-N 570618 US11440884, Example 69 5-hydroxytryptamine receptor 2A Human 20.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570618&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520505 473131852 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205469 COc1cc(ccc1CN(C1CCN(C)CC1)C(=O)Cc1ccc(OCC(C)C)cc1)C(F)(F)F InChI=1S/C27H35F3N2O3/c1-19(2)18-35-24-9-5-20(6-10-24)15-26(33)32(23-11-13-31(3)14-12-23)17-21-7-8-22(27(28,29)30)16-25(21)34-4/h5-10,16,19,23H,11-15,17-18H2,1-4H3 HFPCQXOPCGMAOY-UHFFFAOYSA-N 570619 US11440884, Example 70 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570619&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520717 473131853 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205470 CC(C)COc1ccc(CC(=O)N(Cc2ccc(cc2Cl)C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C26H32ClF3N2O2/c1-18(2)17-34-23-8-4-19(5-9-23)14-25(33)32(22-10-12-31(3)13-11-22)16-20-6-7-21(15-24(20)27)26(28,29)30/h4-9,15,18,22H,10-14,16-17H2,1-3H3 LTBGGJSOGPLZQC-UHFFFAOYSA-N 570621 US11440884, Example 71 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570621&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 156295237 473131855 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205471 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(OC(C)(C)C)cc1 InChI=1S/C25H32F2N2O3/c1-25(2,3)32-22-9-5-18(6-10-22)17-31-24(30)29(21-11-13-28(4)14-12-21)16-19-7-8-20(26)15-23(19)27/h5-10,15,21H,11-14,16-17H2,1-4H3 SRRZMDFVMYOPMF-UHFFFAOYSA-N 570622 US11440884, Example 72 5-hydroxytryptamine receptor 2A Human 0.100 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570622&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 151895888 473131856 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205472 CN1CCC(CC1)N(Cc1ccc(F)cc1F)C(=O)OCc1ccc(cc1)C(C)(F)F InChI=1S/C23H26F4N2O2/c1-23(26,27)18-6-3-16(4-7-18)15-31-22(30)29(20-9-11-28(2)12-10-20)14-17-5-8-19(24)13-21(17)25/h3-8,13,20H,9-12,14-15H2,1-2H3 LDHBYVYQTKJSMA-UHFFFAOYSA-N 570623 US11440884, Example 73 5-hydroxytryptamine receptor 2A Human 0.398 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570623&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 150917355 473131857 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205473 CC(C)Oc1ccc(COC(=O)N(Cc2c(F)cc(Cl)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C24H29ClF2N2O3/c1-16(2)32-20-6-4-17(5-7-20)15-31-24(30)29(19-8-10-28(3)11-9-19)14-21-22(26)12-18(25)13-23(21)27/h4-7,12-13,16,19H,8-11,14-15H2,1-3H3 XNEPDYMEAQTHDA-UHFFFAOYSA-N 570624 US11440884, Example 74 5-hydroxytryptamine receptor 2A Human 0.794 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570624&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 152419711 473131858 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205474 COc1cc(CN(C2CCN(C)CC2)C(=O)OCc2ccc(OC(C)C)cc2)ccc1Cl InChI=1S/C25H33ClN2O4/c1-18(2)32-22-8-5-19(6-9-22)17-31-25(29)28(21-11-13-27(3)14-12-21)16-20-7-10-23(26)24(15-20)30-4/h5-10,15,18,21H,11-14,16-17H2,1-4H3 CTERJOWPACIREB-UHFFFAOYSA-N 570625 US11440884, Example 75 5-hydroxytryptamine receptor 2A Human 158 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570625&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 149960766 473131859 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205475 COc1cc(Cl)ccc1CN(C1CCN(C)CC1)C(=O)OCc1ccc(OC(C)C)cc1 InChI=1S/C25H33ClN2O4/c1-18(2)32-23-9-5-19(6-10-23)17-31-25(29)28(22-11-13-27(3)14-12-22)16-20-7-8-21(26)15-24(20)30-4/h5-10,15,18,22H,11-14,16-17H2,1-4H3 ZIPLHHQIXRNIMF-UHFFFAOYSA-N 570627 US11440884, Example 76 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570627&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 152656339 473131861 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205476 COc1cc(ccc1CN(C1CCN(C)CC1)C(=O)OCc1ccc(OC(C)C)cc1)C(F)(F)F InChI=1S/C26H33F3N2O4/c1-18(2)35-23-9-5-19(6-10-23)17-34-25(32)31(22-11-13-30(3)14-12-22)16-20-7-8-21(26(27,28)29)15-24(20)33-4/h5-10,15,18,22H,11-14,16-17H2,1-4H3 LUAHUKPWDHLHPM-UHFFFAOYSA-N 570628 US11440884, Example 77 5-hydroxytryptamine receptor 2A Human 0.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570628&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 151000629 473131862 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205477 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(cc2Cl)C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C25H30ClF3N2O3/c1-17(2)34-22-8-4-18(5-9-22)16-33-24(32)31(21-10-12-30(3)13-11-21)15-19-6-7-20(14-23(19)26)25(27,28)29/h4-9,14,17,21H,10-13,15-16H2,1-3H3 RGVPHTCZOHNZHH-UHFFFAOYSA-N 570629 US11440884, Example 78 5-hydroxytryptamine receptor 2A Human 25.1 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570629&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 142534520 473131863 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205478 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(cc2F)C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C25H30F4N2O3/c1-17(2)34-22-8-4-18(5-9-22)16-33-24(32)31(21-10-12-30(3)13-11-21)15-19-6-7-20(14-23(19)26)25(27,28)29/h4-9,14,17,21H,10-13,15-16H2,1-3H3 CZMAHIWGORFXJK-UHFFFAOYSA-N 570631 US11440884, Example 79 5-hydroxytryptamine receptor 2A Human 3.98 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570631&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 149992037 473131865 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205479 CC(C)Oc1ccc(COC(=O)N(Cc2cc(F)c(F)cc2F)C2CCN(C)CC2)cc1 InChI=1S/C24H29F3N2O3/c1-16(2)32-20-6-4-17(5-7-20)15-31-24(30)29(19-8-10-28(3)11-9-19)14-18-12-22(26)23(27)13-21(18)25/h4-7,12-13,16,19H,8-11,14-15H2,1-3H3 QDNMFWWLMYHGIR-UHFFFAOYSA-N 570632 US11440884, Example 80 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570632&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 151566446 473131866 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205480 CC(C)Oc1ccc(COC(=O)N(Cc2ccc(F)cc2C(F)(F)F)C2CCN(C)CC2)cc1 InChI=1S/C25H30F4N2O3/c1-17(2)34-22-8-4-18(5-9-22)16-33-24(32)31(21-10-12-30(3)13-11-21)15-19-6-7-20(26)14-23(19)25(27,28)29/h4-9,14,17,21H,10-13,15-16H2,1-3H3 QQRVPUJPICNDQN-UHFFFAOYSA-N 570633 US11440884, Example 81 5-hydroxytryptamine receptor 2A Human 2.0 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570633&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 142534536 473131867 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 1205481 CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2O)C2CCN(C)CC2)cc1 InChI=1S/C25H33FN2O4/c1-18(2)16-31-23-8-4-19(5-9-23)17-32-25(30)28(22-10-12-27(3)13-11-22)15-20-6-7-21(26)14-24(20)29/h4-9,14,18,22,29H,10-13,15-17H2,1-3H3 UWNGAKLKVGVZAZ-UHFFFAOYSA-N 570634 US11440884, Example 82 5-hydroxytryptamine receptor 2A Human 15.8 US Patent 10.7270/Q2ZC864D aid1806796 US11440884 Burstein, ES; Olsson, R; Jansson, KE; Skold, NP; Wahlstrom, LY; Borgstrom, BG; Von Wachenfeldt, H; Bergner, MG 9/13/2022 11/19/2022 ACADIA PHARMACEUTICALS INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570634&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 137520980 473131868 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0